Loading quote...
Beam Therapeutics Inc. (BEAM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. The most recent ex-dividend date was February 4, 2014, with payment scheduled for March 3, 2014. market capitalization is approximately $2.51B.